GF Group Holding
Investor profile
Venture capital
GF Group Holding has backed 2 European tech companies across 3 funding rounds between 2021 and 2023, joining rounds totalling €63M. Most active in Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
2
backed
Active span
2021–2023
3 yrs
Total round €
€63M
sum of rounds joined
Deals by year
distinct rounds / yearGF Group Holding — deals by year — interactive chart.
Data table
| GF Group Holding — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Top sectors
by dealsGF Group Holding — top sectors — interactive chart.
Data table
| GF Group Holding — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsGF Group Holding — stages — interactive chart.
Data table
| GF Group Holding — stages | |
|---|---|
| Seed | 1 |
| Series B | 1 |
| Series C | 1 |
Countries
by dealsGF Group Holding — countries — interactive chart.
Data table
| GF Group Holding — countries | |
|---|---|
| Switzerland | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Memo Therapeutics | Switzerland | 2 | €61M |
| Oncobit | Switzerland | 1 | €2.1M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Memo Therapeutics | Series B | €35M | 2022-02 |
| Memo Therapeutics | Series C | €26M | 2023-11 |
| Oncobit | Seed | €2.1M | 2021-04 |